ST Kelly: Sell Jeno Medical shares and reduce capital to exit Jingzheng Medical.

ST Kelly Announcement: The company held a board meeting on August 4, 2025, to review and approve the proposal to sell the equity of Jeno Medical Management Group Limited and reduce its stake in Shanghai Jingzheng Medical Technology Co., Ltd. The company will sell 36.9000% of the equity indirectly held by Shanghai Jingzheng Medical Technology Co., Ltd to Shanghai Huitian Medical Technology Co., Ltd for 162 million yuan. At the same time, the company plans to exit its investment in Jingzheng Medical through targeted dividends and targeted reductions of capital. After this transaction is completed, the company will no longer hold equity in Jingzheng Medical, Jeno Medical, and its subsidiaries, and these two companies will no longer be included in the company's consolidated financial statements.